A survey of the regulation of human germline genome modification in eighteen countries and the emerging international standards.
"synopsis" may belong to another edition of this title.
Andrea Boggio is Professor of Legal Studies at Bryant University, Rhode Island. He holds a J.S.D. from Stanford University Law School.
Cesare P. R. Romano is Professor of Law and W. Joseph Ford Fellow, at Loyola Law School Los Angeles, Loyola Marymount University, California. He holds an LL.M. from New York University Law School and a Ph.D. from the Graduate Institute of International Studies of the University of Geneva.
Jessica Almqvist is Associate Professor in Public International Law at Universidad Autónoma de Madrid and Senior Research Fellow at the Elcano Royal Institute. She holds a Ph.D. in law from the European University Institute, Florence and a Diploma in graduate studies of political science from University of California, Berkeley.
"About this title" may belong to another edition of this title.
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and medicine, but also law. When the genome of germline cells is modified, the modifications could be inherited, with far-reaching effects in time and scale. Legal systems are struggling with keeping up with the CRISPR revolution and both lawyers and scientists are often confused about existing regulations. This book contains an analysis of the national regulatory framework in eighteen selected countries. Written by national legal experts, it includes all major players in bioengineering, plus an analysis of the emerging international standards and a discussion of how international human rights standards should inform national and international regulatory frameworks. The authors propose a set of principles for the regulation of germline engineering, based on international human rights law, that can be the foundation for regulating heritable gene editing both at the level of countries as well as globally. This book is an accessible guide to navigate how heritable gene editing is regulated around the world, and how international human rights law can inform the debate on how heritable gene editing should be regulated. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9781108718448
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9781108718448
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9781108718448_new
Quantity: Over 20 available
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 680 pages. 8.86x6.02x1.38 inches. In Stock. This item is printed on demand. Seller Inventory # __1108718442
Quantity: 1 available
Seller: Chiron Media, Wallingford, United Kingdom
Paperback. Condition: New. Seller Inventory # 6666-IUK-9781108718448
Quantity: Over 20 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Seller Inventory # C9781108718448
Quantity: Over 20 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. New edition NO-PA16APR2015-KAP. Seller Inventory # 26396107998
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand. Seller Inventory # 401317633
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18396107988
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and medicine, but also law. When the genome of germline cells is modified, the modifications could be inherited, with far-reaching effects in time and scale. Legal systems are struggling with keeping up with the CRISPR revolution and both lawyers and scientists are often confused about existing regulations. This book contains an analysis of the national regulatory framework in eighteen selected countries. Written by national legal experts, it includes all major players in bioengineering, plus an analysis of the emerging international standards and a discussion of how international human rights standards should inform national and international regulatory frameworks. The authors propose a set of principles for the regulation of germline engineering, based on international human rights law, that can be the foundation for regulating heritable gene editing both at the level of countries as well as globally. This book is an accessible guide to navigate how heritable gene editing is regulated around the world, and how international human rights law can inform the debate on how heritable gene editing should be regulated. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9781108718448
Quantity: 1 available